CSF3 and leukemia: It has been previously reported that arsenic trioxide (As2O3) and certain cytokines (IFN-α, G-CSF) were able to sensitize quiescent leukemia cells to chemotherapy cytotoxicity by reducing quiescence depth and waking them up [9].